Aurobindo Pharma Quarterly Results for Trading Insights
AUROPHARMA • Latest quarterly financial performance to support trade journaling in Tickjournal
Latest Quarter Net Profit
₹848 Cr
QSept 2025
Aurobindo Pharma Quarterly Results Key Highlights
- Revenue of ₹8,359 Cr in Sept 2025 (-1.8% vs Mar 2025, +7.4% vs Sept 2024)
- Net Profit of ₹848 Cr in Sept 2025 (-6.1% vs Mar 2025, +3.8% vs Sept 2024)
- EBITDA of ₹1,752 Cr in Sept 2025 (-7.5% vs Mar 2025)
- Operating Margin of 20.0% in Sept 2025 (-1.0pp vs Mar 2025)
- Earnings Per Share of ₹14.61 in Sept 2025 (-6.1% vs Mar 2025)
Aurobindo Pharma Quarterly Results Analysis
| Metric | Sept 2025 | Mar 2025 | Jun 2025 | Dec 2025 | Sept 2024 | QoQ | YoY |
|---|---|---|---|---|---|---|---|
| Revenue (₹ Cr) | 8,359 | 8,516 | 7,899 | 8,793 | 7,783 | -1.8% | 7.4% |
| Net Profit (₹ Cr) | 848 | 903 | 824 | 910 | 817 | - | - |
| EBITDA (₹ Cr) | 1,752 | 1,894 | 1,634 | 1,855 | 1,553 | - | - |
| EPS (₹) | 14.61 | 15.56 | 14.20 | 15.67 | 14.00 | - | - |
| Operating Margin (%) | 20.0% | 21.0% | 20.0% | 19.0% | 19.0% | - | - |
Aurobindo Pharma Share Price Trend Around Quarterly Results
Visualize Aurobindo Pharma's 1-year price movement across quarterly results — ideal for logging trades in Aurobindo Pharma share price
chart using Tickjournal. All values in ₹.
Related Pages for Aurobindo Pharma
Additional stock information and data for AUROPHARMA
Revenue Trend (₹ Cr)
Dec 2025
8,793
Jun 2025
7,899
Mar 2025
8,516
Sept 2025
8,359
Net Profit Trend (₹ Cr)
Dec 2025
910
Jun 2025
824
Mar 2025
903
Sept 2025
848
Operating Margin Trend (%)
Dec 2025
19.0%
Jun 2025
20.0%
Mar 2025
21.0%
Sept 2025
20.0%
Sector Competitors - Quarterly Performance Comparison
Comparing Aurobindo Pharma quarterly results with other companies in Healthcare sector
| Company Latest Quarter | Market Cap (₹ Cr) | Price (₹) | Revenue (₹ Cr) | Net Profit (₹ Cr) | Rev QoQ % | Rev YoY % | Profit Margin % | P/E Ratio |
|---|---|---|---|---|---|---|---|---|
|
Sun Pharmaceutical
Sept 2025 |
₹409,758.43 Cr | 1711.1 | 14,875 | 3,125 | +10.8% | - | 21.0% | 131.6 |
|
Divis Laboratories
Sept 2025 |
₹163,940.12 Cr | 6386.5 | 2,860 | 689 | +7.1% | - | 24.1% | 245.9 |
|
Torrent Pharmaceuti…
Sept 2025 |
₹138,072.20 Cr | 4056.7 | 3,219 | 591 | +11.3% | - | 18.4% | 231.3 |
|
Cipla
Sept 2025 |
₹109,041.12 Cr | 1349.9 | 7,716 | 1,353 | +12.0% | - | 17.5% | 80.7 |
|
Dr Reddys Laborator…
Sept 2025 |
₹104,829.57 Cr | 1270.3 | 9,135 | 1,337 | +1.1% | - | 14.6% | 78.5 |
Sector Quarterly Performance Comparison
Healthcare sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data
QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores
All amounts in ₹ Crores